Comera Life Sciences Holdings Inc (CMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2017 | 12-2006 | |
| Sales | 633 | 320 | 0 | 0 | 0 |
| Cost of Goods | 210 | 161 | N/A | N/A | N/A |
| Gross Profit | 423 | 159 | N/A | N/A | N/A |
| Operating Expenses | 12,603 | 5,856 | 209 | 0 | 0 |
| Operating Income | -11,970 | -5,536 | -209 | N/A | N/A |
| Interest Expense | 20 | 0 | 0 | 0 | 0 |
| Other Income | -6,014 | 84 | -3,072 | 0 | 0 |
| Pre-tax Income | -18,004 | -5,452 | -3,281 | 0 | 0 |
| Net Income Continuous | -18,004 | -5,452 | -3,281 | N/A | N/A |
| Net Income | $-18,004 | $-5,452 | $-3,281 | $N/A | $N/A |
| EPS Basic Total Ops | -1.76 | -1.81 | -0.61 | N/A | N/A |
| EPS Basic Continuous Ops | -1.72 | -1.81 | -1.23 | N/A | N/A |
| EPS Diluted Total Ops | -1.76 | -1.81 | -0.61 | N/A | N/A |
| EPS Diluted Continuous Ops | -1.72 | -1.81 | -1.23 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.94 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-11,876 | $-5,450 | $-209 | $N/A | $N/A |